Lipid-Laden Macrophages in Pulmonary Diseases.
Yin ZhuDooyoung ChoiPayaningal R SomanathDuo ZhangPublished in: Cells (2024)
Pulmonary surfactants play a crucial role in managing lung lipid metabolism, and dysregulation of this process is evident in various lung diseases. Alternations in lipid metabolism lead to pulmonary surfactant damage, resulting in hyperlipidemia in response to lung injury. Lung macrophages are responsible for recycling damaged lipid droplets to maintain lipid homeostasis. The inflammatory response triggered by external stimuli such as cigarette smoke, bleomycin, and bacteria can interfere with this process, resulting in the formation of lipid-laden macrophages (LLMs), also known as foamy macrophages. Recent studies have highlighted the potential significance of LLM formation in a range of pulmonary diseases. Furthermore, growing evidence suggests that LLMs are present in patients suffering from various pulmonary conditions. In this review, we summarize the essential metabolic and signaling pathways driving the LLM formation in chronic obstructive pulmonary disease, pulmonary fibrosis, tuberculosis, and acute lung injury.
Keyphrases
- pulmonary hypertension
- pulmonary fibrosis
- inflammatory response
- fatty acid
- end stage renal disease
- lipopolysaccharide induced
- oxidative stress
- chronic kidney disease
- ejection fraction
- newly diagnosed
- signaling pathway
- emergency department
- mycobacterium tuberculosis
- metabolic syndrome
- prognostic factors
- type diabetes
- adipose tissue
- high fat diet
- peritoneal dialysis
- hepatitis c virus
- hiv infected
- insulin resistance
- skeletal muscle
- induced apoptosis
- case control